BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24034581)

  • 1. Feasibility, effectiveness and safety of transvaginal digoxin administration prior to dilation and evacuation.
    Tocce K; Sheeder JL; Edwards LJ; Teal SB
    Contraception; 2013 Dec; 88(6):706-11. PubMed ID: 24034581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvaginal administration of intraamniotic digoxin prior to dilation and evacuation.
    Gariepy AM; Chen BA; Hohmann HL; Achilles SL; Russo JA; Creinin MD
    Contraception; 2013 Jan; 87(1):76-80. PubMed ID: 22959902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion.
    Molaei M; Jones HE; Weiselberg T; McManama M; Bassell J; Westhoff CL
    Contraception; 2008 Mar; 77(3):223-5. PubMed ID: 18279695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord transection to induce fetal demise prior to second-trimester D&E abortion.
    Tocce K; Leach KK; Sheeder JL; Nielson K; Teal SB
    Contraception; 2013 Dec; 88(6):712-6. PubMed ID: 24034582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized pilot study on the effectiveness and side-effect profiles of two doses of digoxin as fetocide when administered intraamniotically or intrafetally prior to second-trimester surgical abortion.
    Nucatola D; Roth N; Gatter M
    Contraception; 2010 Jan; 81(1):67-74. PubMed ID: 20004276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of digoxin for fetal demise before second-trimester abortion by dilation and evacuation.
    Dean G; Colarossi L; Lunde B; Jacobs AR; Porsch LM; Paul ME
    Contraception; 2012 Feb; 85(2):144-9. PubMed ID: 22067788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of fetal demise before abortion.
    Diedrich J; Drey E;
    Contraception; 2010 Jun; 81(6):462-73. PubMed ID: 20472112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection and extramural delivery with use of digoxin as a feticidal agent.
    Steward R; Melamed A; Kim R; Nucatola D; Gatter M
    Contraception; 2012 Feb; 85(2):150-4. PubMed ID: 22067811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of intraamniotic digoxin to fetal demise.
    Borgatta L; Betstadt SJ; Reed A; Feng KT
    Contraception; 2010 Apr; 81(4):328-30. PubMed ID: 20227550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs used to induce fetal demise prior to abortion: a systematic review.
    Tufa TH; Prager S; Lavelanet AF; Kim C
    Contracept X; 2020; 2():100046. PubMed ID: 33294839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-amniotic digoxin for feticide between 21 and 30 weeks of gestation: a prospective study.
    Sharvit M; Klein Z; Silber M; Pomeranz M; Agizim R; Schonman R; Fishman A
    BJOG; 2019 Jun; 126(7):885-889. PubMed ID: 30703286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraamniotic digoxin administration versus intracardiac or funic potassium chloride administration to induce foetal demise before termination of pregnancy: a prospective study.
    Akalın M; Demirci O; Gokcer O; İsmailov H; Sahap Odacilar A; Dizdarogulları GE; Kahramanoğlu Ö; Ocal A; Bolat G; Eriç Özdemir M
    J Obstet Gynaecol; 2022 Nov; 42(8):3477-3483. PubMed ID: 36369861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of intra-amniotic digoxin administration by obstetrics and gynecology trainees to induce fetal demise prior to medical abortion beyond 20 weeks.
    Tufa TH; Lavelanet AF; Belay L; Seboka B; Bell J
    BMJ Sex Reprod Health; 2020 Oct; 46(4):308-312. PubMed ID: 32241827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation or infection at the time of second trimester induced abortion.
    Roncari D; Politch JA; Sonalkar S; Finneseth M; Borgatta L
    Contraception; 2013 Jan; 87(1):67-70. PubMed ID: 23102591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-fetal Compared With Intra-amniotic Digoxin Before Dilation and Evacuation: A Randomized Controlled Trial.
    White KO; Nucatola DL; Westhoff C
    Obstet Gynecol; 2016 Nov; 128(5):1071-1076. PubMed ID: 27741192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraamniotic ethacridine lactate instillation versus vaginal PGE1 in second trimester termination of pregnancy.
    Berg C; Ludwig M; Sturm N; Diedrich K; Gembruch U; Geipel A
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):193-6. PubMed ID: 16188373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with same-day cervical preparation with Dilapan-S osmotic dilators and vaginal misoprostol before dilatation and evacuation at 18 to 21+6 weeks' gestation.
    Lyus R; Lohr PA; Taylor J; Morroni C
    Contraception; 2013 Jan; 87(1):71-5. PubMed ID: 22898362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation.
    Drey EA; Thomas LJ; Benowitz NL; Goldschlager N; Darney PD
    Am J Obstet Gynecol; 2000 May; 182(5):1063-6. PubMed ID: 10819828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induced termination of second and third trimester pregnancy in women with scarred uterus].
    Zou LY; Fan L
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):17-21. PubMed ID: 20367920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.